X·CON 2019 – Healthtech →
Professor of Systems Biology, Columbia University
Vice president, chief strategy and operating officer of the Texas Medical Center
Software Engineer at Skelmir
Managing Partner at Pappas Ventures
Partner at New Enterprise Associates
CEO and Co-Founder, Tamr
Serial Entrepreneur and Investor
October 22, 2019 · Boston
October 29, 2019 · San Francisco
October 31, 2019 · San Diego
Matthew Scholz is the CEO of Immusoft, a (currently) Seattle based biotech startup that is commercializing technology to program the human immune system.
If Seattle is to occupy a future place of dominance in the biotech world, it must foster more of an “incubator” culture. There is a “valley of death” between the well-funded... Read more »
Xconomy Insight · Webinar
Potential cures and treatments for diseases are on the horizon for a growing number of patients, thanks to recent breakthroughs in CRISPR gene-editing technologies and in cell and gene therapy.
Sponsored · Whitepaper
Implementing electronic solutions for risk mitigation
Remain compliant and ensure optimal productivity
Tax credits help tech innovators attract capital, fuel growth
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.